The current influenza season has emerged as one of the most significant public health challenges in recent years. With hospitalization rates reaching levels not seen since before the COVID-19 pandemic and widespread outbreaks affecting communities across the nation, health officials have classified this as a high severity flu season for all age groups.
This article examines the factors contributing to this severe season, compares it to previous outbreaks, and provides guidance on prevention and treatment.
Download our free guide that has over 100+ of the best tips for healthy lungs.
Assessing the Severity of the Current Season
According to surveillance data from the Centers for Disease Control and Prevention, the 2024-2025 flu season has shown unusually high activity levels. Preliminary estimates indicate there have been at least 37 million illnesses, 480,000 hospitalizations, and 21,000 deaths attributed to influenza so far this season. These numbers continue to rise as the season progresses.
What makes this season particularly concerning is the rate of outpatient visits for influenza-like illness, which reached 8% of all medical visits during the peak weeks. This percentage represents the highest level observed since the 2009 H1N1 pandemic. Nearly all regions of the country have reported high or very high influenza activity, with some areas experiencing severe strain on healthcare systems.
Pediatric cases have been especially troubling this season. As of the latest reports, 98 children have died from flu-related complications. Several school districts have temporarily closed due to high absenteeism rates among both students and staff. Hospitals in affected regions report increased admissions for flu-related pneumonia and other secondary infections.
Key Factors Driving the Severe Season
Several interconnected factors have contributed to making this flu season particularly severe. Understanding these elements helps explain why this year differs from recent seasons and provides insight into how future outbreaks might develop.
The predominant circulating strains this season have been influenza A viruses, specifically H3N2 and H1N1 variants. These strains historically cause more severe illness and spread more rapidly than influenza B viruses. The H3N2 strain is particularly concerning because it tends to mutate frequently, making it harder for immune systems to recognize and respond effectively.
Vaccination rates have declined significantly compared to pre-pandemic levels. Current estimates suggest only about 44% of the U.S. population has received this year’s flu vaccine. This represents a substantial drop from previous years and leaves a larger portion of the population vulnerable to infection. The decline is especially pronounced among children, with vaccination rates falling from 59% in the 2019-2020 season to just 46% this year.
The impact of pandemic-related measures continues to influence respiratory virus patterns. During the peak COVID-19 years, widespread mask use and social distancing dramatically reduced influenza transmission. While this helped control flu outbreaks at the time, it also meant fewer people developed natural immunity through exposure. Now that most mitigation measures have ended, the population has less protection against circulating strains.
This season has followed an unusual pattern in terms of timing. Instead of peaking in December or early January as typically occurs, influenza activity surged in late January and remained high through February. Some regions are now experiencing a second wave of cases, prolonging the season’s impact on communities and healthcare systems.
The concurrent circulation of other respiratory viruses has complicated the situation. While COVID-19 activity has been relatively low this winter, RSV and other respiratory pathogens have continued to spread. This has led to cases of co-infection and made diagnosis more challenging. Many people with flu-like symptoms don’t get tested specifically for influenza, which may lead to underestimates of the true case numbers.
Comparison to Previous Influenza Seasons
When examining the current season in historical context, several comparisons stand out. The 2009-2010 H1N1 pandemic season serves as one reference point, though that event involved a novel virus strain to which the population had little immunity. The 2017-2018 season provides a more relevant comparison, as it was also dominated by H3N2 viruses and resulted in approximately 61,000 deaths.
The current season appears on track to approach or possibly exceed the severity of the 2017-2018 outbreak. Hospitalization rates for influenza have already surpassed those seen in recent years, including seasons heavily impacted by COVID-19. One notable difference is the age distribution of severe cases, with this season showing increased impact across all age groups rather than concentrating in specific demographics.
Public health officials note that the mortality figures from this season may ultimately be higher than currently reported due to delays in death certificate processing and the potential for secondary complications. Pneumonia and other respiratory conditions that develop following influenza infection can contribute to mortality weeks after the initial illness.
The Critical Role of Vaccination
Despite the challenges posed by this severe season, vaccination remains the most effective tool for prevention. Early estimates suggest this year’s vaccine reduces the risk of hospitalization by 41-55% in adults and 63-78% in children. While these numbers indicate moderate effectiveness, they demonstrate that vaccination continues to provide important protection.
The composition of the annual flu vaccine is determined months in advance based on global surveillance data. This process allows time for production and distribution but can sometimes result in mismatches if circulating strains evolve significantly. This year’s vaccine appears well-matched to the predominant H3N2 and H1N1 strains, though its effectiveness can vary by individual factors such as age and immune status.
Health departments across the country have intensified vaccination efforts in response to the severe season. Many clinics offer extended hours and walk-in availability to make getting vaccinated more convenient. Pharmacies and healthcare providers emphasize that vaccination can still provide benefits even late in the season, as influenza activity often continues into spring.
Additional Prevention Strategies
Beyond vaccination, several evidence-based strategies can help reduce influenza transmission. Frequent hand washing with soap and water remains one of the simplest yet most effective ways to prevent infection. Alcohol-based hand sanitizers can serve as an alternative when soap isn’t available.
Respiratory etiquette plays an important role in controlling spread. Covering coughs and sneezes with tissues or the inside of the elbow helps prevent virus transmission. People experiencing flu-like symptoms should stay home from work or school until fever-free for at least 24 hours without medication.
Environmental cleaning practices can reduce surface contamination. Regular disinfection of high-touch surfaces like doorknobs, light switches, and electronic devices helps minimize indirect transmission. Improved ventilation in indoor spaces may also decrease the concentration of airborne virus particles.
For high-risk individuals, including older adults and those with chronic medical conditions, antiviral medications can provide additional protection when taken as prophylaxis after exposure. These prescription medications work best when started within 48 hours of symptom onset but may still provide benefits when initiated later in the course of illness.
Emerging Public Health Concerns
While influenza remains the most immediate threat, public health officials are monitoring other concerning developments. Avian influenza cases in humans have increased slightly, though the risk to the general population remains low. These cases primarily occur in people with direct exposure to infected birds or livestock.
Measles outbreaks have also gained attention, with several states reporting cases primarily among unvaccinated individuals. These outbreaks serve as a reminder of the importance of maintaining high vaccination coverage for all preventable diseases. The combination of multiple circulating pathogens creates additional challenges for healthcare systems already strained by influenza.
Looking Ahead
As the season continues to unfold, public health agencies emphasize the importance of ongoing vigilance. Influenza activity typically begins to decline in March or April, but late-season waves can occur. The experience of this severe season highlights the need for sustained investment in vaccine development, public health infrastructure, and community education.
Researchers will continue to study this season’s patterns to improve future preparedness. Lessons learned may inform strategies for vaccine distribution, timing of public health messaging, and approaches to managing healthcare system capacity during peak demand periods.
For individuals, the takeaway message remains clear: vaccination, combined with basic preventive measures, offers the best protection against influenza and its complications. Even during a severe season, these actions can make a meaningful difference in personal and community health outcomes.
Health professionals recommend staying informed through reliable sources like the CDC and local health departments. As the situation evolves, these agencies provide updated guidance on prevention, testing, and treatment options. By working together and following evidence-based recommendations, communities can weather this challenging season and build resilience for the future.
Final Thoughts
The 2024-2025 influenza season has proven exceptionally severe due to a confluence of factors, including the predominance of aggressive H3N2 and H1N1 strains, declining vaccination rates, and reduced population immunity following pandemic-era protections.
While the season’s intensity has strained healthcare systems and communities nationwide, it serves as a powerful reminder of influenza’s persistent threat and the importance of proactive public health measures. Vaccination remains our most effective defense, significantly reducing severe outcomes even when imperfectly matched to circulating strains.
As we navigate the remainder of this challenging season, maintaining basic preventive practices—from hand hygiene to respiratory etiquette—can help mitigate spread. This experience underscores the need for sustained investment in vaccine research, public health infrastructure, and community education to better prepare for future respiratory virus threats.
Written by:
John Landry is a registered respiratory therapist from Memphis, TN, and has a bachelor's degree in kinesiology. He enjoys using evidence-based research to help others breathe easier and live a healthier life.
References
- Boktor SW, Hafner JW. Influenza. [Updated 2023 Jan 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.